Evidence map›Paper›PMID 36495011›Full record

ArticleVeterinary ophthalmology2023

Alternative splicing in CEP290 mutant cats results in a milder phenotype than LCA

Andrea L Minella, Kristina Narfström Wiechel, Simon M Petersen-Jones

Open access · hybridAbstract read
In one paragraph

Article in Veterinary ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Animal models for the evaluation of retinal stem cell therapies.Progress in retinal and eye research · 2025
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Andrea L MinellaDepartment of Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, USA.ORCID https://orcid.org/0000-0002-4056-4711
Kristina Narfström WiechelDepartment of Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, Mssouri, USA.ORCID https://orcid.org/0000-0001-7538-7711
Simon M Petersen-JonesDepartment of Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, USA.ORCID https://orcid.org/0000-0002-7410-2304
Michigan State University · USMissouri College · US

Funding

CVM Center for Feline Health and Well-BeingMyers-Dunlap EndowmentThe Cotter EndowmentThe Grousbeck Family Foundation
6 · The paper itself

Abstract

purposeThe rdAc cat has an intronic mutation in the centrosomal 290 kDa (CEP290) gene resulting in a frameshift and a premature stop codon (c.6960 + 9 T > G, p.Ile2321AlafsTer3) predicted to truncate the protein by 157 amino acids. CEP290 mutations in human patients cause a range or phenotypes including syndromic conditions and severe childhood loss of vision while the rdAc cat has a milder phenotype. We sought to further characterize the effect of rdAc mutation on CEP290 expression.

methodsTaqMan quantitative real-time polymerase chain reaction assays were used to compare wildtype and truncated transcript levels. Relative protein abundance was analyzed by Western blot. Immunohistochemistry (IHC) was performed to detect CEP290 protein.

resultsCEP290 mutant cats show low-level (17.4% of wildtype cats) use of the wildtype splice site and usage of the mutant splice site. Western analysis shows retina from cats homozygous for the mutation has CEP290 protein that likely comprises a combination of both wildtype and truncated protein. IHC detects CEP290 in affected and control retina labeling the region of the interconnecting cilium.

conclusionsThe comparably milder phenotype of CEP290 mutant cats is likely due to the retained production of some full-length CEP290 protein with possible functional contributions from presence of truncated protein.

Indexed as

Alternative SplicingNeoplasm ProteinsAnimalsAntigens, NeoplasmCell Cycle ProteinsCytoskeletal ProteinsHumansMutationPhenotypeAntigens, NeoplasmCell Cycle ProteinsCep290 protein, humanCytoskeletal ProteinsNeoplasm ProteinsCEP290Leber congenital amaurosisprogressive retinal atrophysplice site mutation

Identifiers

PMID36495011
PMCPMC10107307
OpenAlexW4311025599

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.